Mitumomab
From Wikipedia, the free encyclopedia
Mitumomab?
|
|
Therapeutic monoclonal antibody | |
Source | Mouse |
Target | CD3 ganglioside |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | ? |
Mol. mass | ? |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Mitumomab is a mouse, anti-Idiotypic monoclonal antibody that targets GD3 ganglioside, which is over-expressed predominantly on tumours origination from the neuroectoderm.
|